pedro villarejo campos

Has grant

Associate Professor

Universidad Complutense de Madrid Facultad de Medicina

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

ORCID

Google Scholar

About

Pedro Villarejo Campos is an Associate Professor at Universidad Autónoma de Madrid Facultad de Medicina, Spain. His research primarily focuses on surgical oncology, hemodynamic optimization during major surgeries, and innovative cancer treatment methodologies. He has recently contributed to significant studies involving techniques in colorectal cancer treatment, use of advanced imaging in diagnosing primary hyperparathyroidism, and the effectiveness of immunotherapy approaches against peritoneal carcinomatosis.

Recent Grants

Grant: Close

DISEÑO DE MATRICES POLIMERICAS PARA LA DOSIFICACION DE SUSTANCIAS BIOACTIVAS MEDIANTE TECNOLOGIA SUPERCRITICA.

Open Date: 2016-01-01

Close Date:

Grant: Close

TEST DE SEGURIDAD Y EFECTIVIDAD EN EL CONTROL HEMODINÁMICO, FLUIDOS ,Y DISTRIBUCIÓN DEL FÁRMACO DURANTE EL DESARROLLO DE UN MODELO DE ACCESO LAPAROSCÓPICO PARA CIRUGÍA CITORREDUCTORA Y QUIMIOTERAPIA INTRAABDOMINAL HIPERTÉRMICA MEDIANTE UN SISTEMA CERRADO CON RECIRCULACIÓN DE CO2, EN UN MODELO EXPERIMENTAL PORCINO

Open Date: 2015-01-01

Close Date:

Grant: Close

Monitorización del volumen intravascular mediante GEDI (Volumen global telediastólico) vs a presión venosa central (PVC) en el control de pérdidas sanguineas durante la resección de metástasis hepáticas de origen colorrectal que ha recibido quimioterapia previa

Open Date: 2014-01-01

Close Date: 2015-01-01

Grant: Close

Utilidad de la quimioterapia intrabdominal hipertérmica mediante gemcitabina para la inhibición de la progresión tumoral en un modelo experimenta de carcinomatosis peritoneal pancreática, en relación a su comportamiento con las células troncales tumorales. CD133+ CXCR4+

Open Date: 2012-12-01

Close Date: 2014-12-01

Grant: Close

Quimiohipertermia intraperitoneal con paclitaxel en el tratamiento de la carcinomatosis ovárica

Open Date: 2011-09-01

Close Date: 2014-12-01

pedro villarejo campos

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (27)

Personalizezed Hemodynamic Optimization Using Stroke Volume, Pulse Pressure Variation, and Continuous Cardiac Index in Major Liver Surgery: A Randomized Controlled Trial

Characterization of collagen profile in peritoneal metastases of colorectal cancer

Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer

Inflammatory Fibroid Polyp (Vanek’s Tumor): A Retrospective Multicentric Analysis of 67 Cases

A Step-By-Step Guide for Robotic Blumgart Pancreaticojejunostomy

Differences in histopathologic features and diagnostic performance of <sup>99m</sup>Tc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and <sup>18</sup>F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism

Long‐term intraperitoneal access with description of a new access catheter

Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination

Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

Value of three-dimensional reconstruction for non-invasive estimation of PCI in patients with peritoneal carcinomatosis of colorectal origin: A proof of concept

Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study

POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer A Phase 3 Randomized Clinical Trial

First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Therapeutic effect of adipose-derived mesenchymal stem cells in a porcine model of abdominal sepsis

Rates of Anastomotic Complications and Their Management Following Esophagectomy

A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy.

Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): A randomized phase III study

Portal gas and gastric pneumatosis. A story with happy ending.

Chemical Scalpel: An Experimental Collagenase-Based Treatment for Peritoneal Adhesions.

Extended totally extraperitoneal (eTEP) treatment for lateral primary and incisional hernias. New approach to old problems.

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.

TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response.

Body Mass Index impact on Extended Total Extraperitoneal Ventral Hernia Repair: a comparative study.

Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects.

Collaborators (14)

Sonia Castillo‐Lluva

Hana Faltova

Guillermo Velasco

Manuel Artiles-Armas

Garcia-Foncillas J

Dimitrios N. Raptis

Hector Guadalajara

Todor Dzhendov

Marc Vallve-Bernal

Mariano Amo-Salas

Javier Martinez-Useros

Damián García-Olmo

Santiago González-Moreno

MARIA DEL MAR;MARIA DEL MAR LORENTE PEREZ;LORENTE PEREZ

How do I reach out?

Meet Kite AI